S2Medical AB Class B (S21) Stock Statistics & Valuation Metrics

S2Medical AB Class B has a market cap or net worth of €834.42K. The enterprise value is €4.15.

S2Medical AB Class B has 1,797,314,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

S2Medical AB Class B’s return on equity (ROE) is -1.02 and return on invested capital (ROIC) is -27.16%.

The current PE Ratio of S2Medical AB Class B is ―. S2Medical AB Class B’s PEG ratio is 0.00423.

In the last 12 months, S2Medical AB Class B had revenue of 14.36M and earned -10.09M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -444.79K and capital expenditures 0.00, giving a free cash flow of -444.79K billion.

S2Medical AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

S2Medical AB Class B upcoming earnings date is Nov 30, 2026, TBA (Confirmed).

S2Medical AB Class B as a current ratio of 0.56, with Debt / Equity ratio of 0.00%

In the past 12 months, S2Medical AB Class B has paid 0.00 in taxes.

S2Medical AB Class B EV to EBITDA ratio is -5.88, with an EV/FCF ratio of -6.13.

S2Medical AB Class B has €564.00K in cash and marketable securities with €0.00 in debt, giving a net cash position of €564.00K billion.

Gross margin is 89.39%, with operating margin of -18.67%, and net profit margin of -70.27%.

The average price target for S2Medical AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―